{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:12:56Z","timestamp":1788541976500,"version":"build-2803163510"},"reference-count":26,"publisher":"Japanese Society of Internal Medicine","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2024,5,15]]},"DOI":"10.2169\/internalmedicine.2437-23","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T18:54:20Z","timestamp":1695927260000},"page":"1399-1404","source":"Crossref","is-referenced-by-count":6,"title":["Lithium-induced Nephrogenic Diabetes Insipidus with Efficacy of Desmopressin in Combination with Thiazide Diuretics and Non-steroidal Anti-inflammatory Drugs: A Case Report with a Review of the Literature"],"prefix":"10.2169","volume":"63","author":[{"given":"Takanobu","family":"Jinnouchi","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Diabetes, NTT Medical Center Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehiro","family":"Yoshimoto","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, NTT Medical Center Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Ogino","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine, NTT Medical Center Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoatsu","family":"Oji","sequence":"additional","affiliation":[{"name":"Department of Psychosomatic Medicine, NTT Medical Center Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Diabetes, NTT Medical Center Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moeller HB, Rittig S, Fenton RA. Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment. Endocr Rev 34: 278-301, 2013.","DOI":"10.1210\/er.2012-1044"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bichet DG. Nephrogenic diabetes insipidus. Adv Chronic Kidney Dis 13: 96-104, 2006.","DOI":"10.1053\/j.ackd.2006.01.006"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bockenhauer D, Bichet DG. Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus. Nat Rev Nephrol 11: 576-588, 2015.","DOI":"10.1038\/nrneph.2015.89"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 63: 607-630, 2001.","DOI":"10.1146\/annurev.physiol.63.1.607"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Sands JM, Bichet DG. Nephrogenic diabetes insipidus. Ann Intern Med 144: 186-194, 2006.","DOI":"10.7326\/0003-4819-144-3-200602070-00007"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Garofeanu CG, Weir M, Rosas-arellano MP, Henson G, Garg AX, Clark WF. Causes of reversible nephrogenic diabetes insipidus: a systematic review. Am J Kidney Dis 45: 626-637, 2005.","DOI":"10.1053\/j.ajkd.2005.01.008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. M\u00fcller-Oerlinghausen B, Bergh\u00f6fer A, Bauer M. Bipolar disorder. Lancet 359: 241-247, 2002.","DOI":"10.1016\/S0140-6736(02)07450-0"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Gr\u00fcnfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol 5: 270-276, 2009.","DOI":"10.1038\/nrneph.2009.43"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Bendz H, Sj\u00f6din I, Aurell M. Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study. Nephrol Dial Transplant 11: 457-460, 1996.","DOI":"10.1093\/ndt\/11.3.457"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Robinson AG. DDAVP in the treatment of central diabetes insipidus. N Engl J Med 294: 507-511, 1976.","DOI":"10.1056\/NEJM197603042941001"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Boton R, Gaviria M, Batlle DC. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10: 329-345, 1987.","DOI":"10.1016\/S0272-6386(87)80098-7"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Christensen BM, Marples D, Kim YH, Wang W, Fr\u00f8kiaer J, Nielsen S. Changes in cellular composition of kidney collecting duct cells in rats with lithium-induced NDI. Am J Physiol Cell Physiol 286: 952-964, 2004.","DOI":"10.1152\/ajpcell.00266.2003"},{"key":"13","unstructured":"13. Trepiccione F, Christensen BM. Lithium-induced nephrogenic diabetes insipidus: new clinical and experimental findings. J Nephrol 23: 43-48, 2010."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kim GH, Choi NW, Jung JY, et al. Treating lithium-induced nephrogenic diabetes insipidus with a COX-2 inhibitor improves polyuria via upregulation of AQP2 and NKCC2. Am J Physiol 294: 702-709, 2008.","DOI":"10.1152\/ajprenal.00366.2007"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Swaminathan R. Hyperosmolar coma and lithium-induced diabetes insipidus. Lancet 346: 413-417, 1995.","DOI":"10.1016\/S0140-6736(95)92783-2"},{"key":"16","unstructured":"16. Fujimoto M, Okada S, Kawashima Y, et al. Clinical overview of nephrogenic diabetes insipidus based on a nationwide survey in Japan. Yonago Acta Med 57: 85-91, 2014."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Mizuno H, Fujimoto S, Sugiyama Y, et al. Successful treatment of partial nephrogenic diabetes insipidus with thiazide and desmopressin. Horm Res 59: 297-300, 2003.","DOI":"10.1159\/000070629"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Bockenhauer D, Carpentier E, Rochdi D, et al. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron Physiol 114: 1-10, 2010.","DOI":"10.1159\/000245059"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. M\u00fcller D, Marr N, Ankermann T, Eggert P, Deen PMT. Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus. Lancet 359: 495-497, 2002.","DOI":"10.1016\/S0140-6736(02)07667-5"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ikegawa K, Hachiya R, Akiba K, Hasegawa Y. Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report. Clin Pediatr Endocrinol 31: 87-92, 2022.","DOI":"10.1297\/cpe.2021-0032"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Kamath C, Govindan J, Premawardhana AD, Wood SJ, Adlan MA, Premawardhana LD. Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithium-induced multiple endocrinopathy. Clin Med 13: 407-410, 2013.","DOI":"10.7861\/clinmedicine.13-4-407"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Weinstock RS, Moses AM. Desmopressin and indomethacin therapy for nephrogenic diabetes insipidus in patients receiving lithium carbonate. South Med J 83: 1475-1477, 1990.","DOI":"10.1097\/00007611-199012000-00026"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Stasior DS, Kikeri D, Duel B, Seifter JL. Nephrogenic diabetes insipidus responsive to indomethacin plus dDAVP. N Engl J Med 324: 850-851, 1991.","DOI":"10.1056\/NEJM199103213241215"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. \u015eenocak ET, Eralp H, Kayata\u015f K. Lithium-induced nephrogenic diabetes insipidus responsive to desmopressin. Acta Endocrinol 15: 270-271, 2019.","DOI":"10.4183\/aeb.2019.270"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Christ CM, Gaisl O. Diabetes insipidus.. Presse Med 50: 104093, 2021.","DOI":"10.1016\/j.lpm.2021.104093"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf) 90: 23-30, 2019.","DOI":"10.1111\/cen.13866"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/10\/63_2437-23\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T23:28:15Z","timestamp":1715988495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/63\/10\/63_2437-23\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,15]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.2437-23","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,15]]},"article-number":"2437-23"}}